Who this is for
Founders approaching an institutional round; management teams preparing for strategic investment or a corporate partnership; and organizations entering cross-border conversations where the counterparty's evaluation norms differ materially from their own. The Japan dimension matters here more than most teams anticipate: Japanese corporate and strategic investors evaluate on a different timescale, weight different evidence, and read absence of preparation as a signal about future reliability.
The work
- The equity story. Not the pitch narrative, the underlying logic of why this business compounds, stated in terms a counterparty can test.
- Evidence architecture. Which claims need proof, what proof exists, and what must be built before the conversation begins.
- Adversarial review. Sitting on the other side of the table and asking the questions the company would least like to answer.
- Counterparty mapping. Which investors or partners are a genuine fit, and what each will actually optimize for.
- Cross-border translation. Adapting materials, cadence, and expectations for Japanese or other counterparties without diluting the case.
Readiness is not polish. It is having already survived, in private, the interrogation you are about to face in public.
